-
과장
김우형
- 핵의학과 핵의학센터
- 전문진료 종양핵의학, 신경핵의학, 심장핵의학, 핵의학 체내검사, 방사성동위원소치료(갑상선암, 갑상선기능항진증 등)
김우형 과장의 진료시간표
| 진료과/센터 | 월 | 화 | 수 | 목 | 금 | 토 |
|---|---|---|---|---|---|---|
| 핵의학과 |
- 학력 및 경력
- 학술활동
- 논문
학력
원광대학교 대학원 의학석사
원광대학교 대학원 의학박사
경력
원광대학교병원 핵의학과 전공의
서울대학교병원 연구전임의
전북대학교병원 핵의학과 임상전임의
대한핵의학회 Young Investigator’s Award (2014)
대한핵의학회 정회원
1. Kim W, Park JS, Song JH, et al. Boron Neutron Capture Therapy in Recurrent High-Grade Gliomas: Safety, Efficacy, and Pharmacokinetics From a Multicenter, Dose-Escalation Phase 1 Trial. Adv Radiat Oncol. 2026;11(1):101947. doi:10.1016/j.adro.2025.101947*
2. Kim W, Won JY, Yi J, et al. PK Modeling of L-4-Boronophenylalanine and Development of Bayesian Predictive Platform for L-4-Boronophenylalanine PKs for Boron Neutron Capture Therapy. Pharmaceuticals (Basel). 2024;17(3):301. doi:10.3390/ph17030301*
3. Seo IH, Seo HJ, Na D, et al. The therapeutic effects on U87 and SAS cells using Proton Linac based Boron Neutron Capture Therapy in Korea. Appl Radiat Isot. 2023;197:110794. doi:10.1016/j.apradiso.2023.110794
4. Park JY, Song MG, Kim WH, et al. Versatile and Finely Tuned Albumin Nanoplatform based on Click Chemistry. Theranostics. 2019;9(12):3398-3409. doi:10.7150/thno.33143*
5. Park S, Ha S, Kwon HW, et al. Prospective Evaluation of Changes in Tumor Size and Tumor Metabolism in Patients with Advanced Gastric Cancer Undergoing Chemotherapy: Association and Clinical Implication. J Nucl Med. 2017;58(6):899-904. doi:10.2967/jnumed.116.182675
6. Kim WH, Kim CG, Kim MH, et al. Preclinical evaluation of isostructural Tc-99m- and Re-188-folate-Gly-Gly-Cys-Glu for folate receptor-positive tumor targeting. Ann Nucl Med. 2016;30(5):369-79. doi:10.1007/s12149-016-1072-0*
7. Kim DW, Kim WH, Kim MH, Choi KH, Kim CG. Detection of Extramedullary Multiple Myeloma in Liver by FDG-PET/CT. Nucl Med Mol Imaging. 2014;48(2):166-8. doi:10.1007/s13139-013-0256-y
8. Kim MH, Kim WH, Kim CG, Kim DW. Os vesalianum pedis detected with bone SPECT/CT. Clin Nucl Med. 2014;39(2):e190-2. doi:10.1097/RLU.0000000000000305
9. Kim WH, Kim MH, Kim CG, Kim DW. Synovial hemangioma of Hoffa fat pad demonstrated by RBC SPECT/CT. Clin Nucl Med. 2014;39(9):806-7. doi:10.1097/RLU.0b013e3182a23d5a*
10. Kim DW, Kim WH, Kim MH, Kim CG, Oh CS, Min JJ. Synthesis and evaluation of Tc-99m DTPA-glutathione as a non-invasive tumor imaging agent in a mouse colon cancer model. Ann Nucl Med. 2014;28(5):447-54. doi:10.1007/s12149-014-0835-8
11. Kim DW, Kim WH, Kim CG. Abdominal aortic aneurysm with bony erosion mimicking recurrent non-Hodgkin lymphoma on FDG PET/CT. Clin Nucl Med. 2013;38(5):e233-5. doi:10.1097/RLU.0b013e3182638301
12. Kim WH, Kim DW, Kim CG, Kim MH. Additional Detection of Multiple Osteomas in a Patient with Gardner's Syndrome by Bone SPECT/CT. Nucl Med Mol Imaging. 2013;47(4):297-8. doi:10.1007/s13139-013-0225-5*
13. Kim CG, Kim WH, Kim MH, Kim DW. Direct Determination of Lean Body Mass by CT in F-18 FDG PET/CT Studies: Comparison with Estimates Using Predictive Equations. Nucl Med Mol Imaging. 2013;47(2):98-103. doi:10.1007/s13139-013-0207-7
14. Kim DW, Kim WH, Kim MH, et al. Effect of 18F-FDG administration on measurements of bone mineral density and body composition by dual-energy X-ray absorptiometry. J Clin Densitom. 2013;16(3):283-286. doi:10.1016/j.jocd.2013.03.001
15. Kim DW, Kim WH, Kim MH, Kim CG. Novel Tc-99m labeled ELR-containing 6-mer peptides for tumor imaging in epidermoid carcinoma xenografts model: a pilot study. Ann Nucl Med. 2013;27(10):892-7. doi:10.1007/s12149-013-0766-9
16. Kim WH, Kim CG, Kim DW. Comparison of SUVs Normalized by Lean Body Mass Determined by CT with Those Normalized by Lean Body Mass Estimated by Predictive Equations in Normal Tissues. Nucl Med Mol Imaging. 2012;46(3):182-8. doi:10.1007/s13139-012-0146-8*
17. Kim DW, Kim WH, Kim CG. Dual-time-point FDG PET/CT: Is It Useful for Lymph Node Staging in Patients with Non-Small-Cell Lung Cancer? Nucl Med Mol Imaging. 2012;46(3):196-200. doi:10.1007/s13139-012-0141-0
18. Kim WH, Kim CG, Kim DW. Optimal CT Number Range for Adipose Tissue When Determining Lean Body Mass in Whole-Body F-18 FDG PET/CT Studies. Nucl Med Mol Imaging. 2012;46(4):294-9. doi:10.1007/s13139-012-0175-3*
19. Park SA, Yang CY, Choi SS, Kim WH. Assessment of cerebral hemodynamics to acetazolamide using brain perfusion SPECT in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Clin Nucl Med. 2011;36(2):158-9. doi:10.1097/RLU.0b013e3182073c0f*제1저자(공동 제1저자 포함)
2. Kim W, Won JY, Yi J, et al. PK Modeling of L-4-Boronophenylalanine and Development of Bayesian Predictive Platform for L-4-Boronophenylalanine PKs for Boron Neutron Capture Therapy. Pharmaceuticals (Basel). 2024;17(3):301. doi:10.3390/ph17030301*
3. Seo IH, Seo HJ, Na D, et al. The therapeutic effects on U87 and SAS cells using Proton Linac based Boron Neutron Capture Therapy in Korea. Appl Radiat Isot. 2023;197:110794. doi:10.1016/j.apradiso.2023.110794
4. Park JY, Song MG, Kim WH, et al. Versatile and Finely Tuned Albumin Nanoplatform based on Click Chemistry. Theranostics. 2019;9(12):3398-3409. doi:10.7150/thno.33143*
5. Park S, Ha S, Kwon HW, et al. Prospective Evaluation of Changes in Tumor Size and Tumor Metabolism in Patients with Advanced Gastric Cancer Undergoing Chemotherapy: Association and Clinical Implication. J Nucl Med. 2017;58(6):899-904. doi:10.2967/jnumed.116.182675
6. Kim WH, Kim CG, Kim MH, et al. Preclinical evaluation of isostructural Tc-99m- and Re-188-folate-Gly-Gly-Cys-Glu for folate receptor-positive tumor targeting. Ann Nucl Med. 2016;30(5):369-79. doi:10.1007/s12149-016-1072-0*
7. Kim DW, Kim WH, Kim MH, Choi KH, Kim CG. Detection of Extramedullary Multiple Myeloma in Liver by FDG-PET/CT. Nucl Med Mol Imaging. 2014;48(2):166-8. doi:10.1007/s13139-013-0256-y
8. Kim MH, Kim WH, Kim CG, Kim DW. Os vesalianum pedis detected with bone SPECT/CT. Clin Nucl Med. 2014;39(2):e190-2. doi:10.1097/RLU.0000000000000305
9. Kim WH, Kim MH, Kim CG, Kim DW. Synovial hemangioma of Hoffa fat pad demonstrated by RBC SPECT/CT. Clin Nucl Med. 2014;39(9):806-7. doi:10.1097/RLU.0b013e3182a23d5a*
10. Kim DW, Kim WH, Kim MH, Kim CG, Oh CS, Min JJ. Synthesis and evaluation of Tc-99m DTPA-glutathione as a non-invasive tumor imaging agent in a mouse colon cancer model. Ann Nucl Med. 2014;28(5):447-54. doi:10.1007/s12149-014-0835-8
11. Kim DW, Kim WH, Kim CG. Abdominal aortic aneurysm with bony erosion mimicking recurrent non-Hodgkin lymphoma on FDG PET/CT. Clin Nucl Med. 2013;38(5):e233-5. doi:10.1097/RLU.0b013e3182638301
12. Kim WH, Kim DW, Kim CG, Kim MH. Additional Detection of Multiple Osteomas in a Patient with Gardner's Syndrome by Bone SPECT/CT. Nucl Med Mol Imaging. 2013;47(4):297-8. doi:10.1007/s13139-013-0225-5*
13. Kim CG, Kim WH, Kim MH, Kim DW. Direct Determination of Lean Body Mass by CT in F-18 FDG PET/CT Studies: Comparison with Estimates Using Predictive Equations. Nucl Med Mol Imaging. 2013;47(2):98-103. doi:10.1007/s13139-013-0207-7
14. Kim DW, Kim WH, Kim MH, et al. Effect of 18F-FDG administration on measurements of bone mineral density and body composition by dual-energy X-ray absorptiometry. J Clin Densitom. 2013;16(3):283-286. doi:10.1016/j.jocd.2013.03.001
15. Kim DW, Kim WH, Kim MH, Kim CG. Novel Tc-99m labeled ELR-containing 6-mer peptides for tumor imaging in epidermoid carcinoma xenografts model: a pilot study. Ann Nucl Med. 2013;27(10):892-7. doi:10.1007/s12149-013-0766-9
16. Kim WH, Kim CG, Kim DW. Comparison of SUVs Normalized by Lean Body Mass Determined by CT with Those Normalized by Lean Body Mass Estimated by Predictive Equations in Normal Tissues. Nucl Med Mol Imaging. 2012;46(3):182-8. doi:10.1007/s13139-012-0146-8*
17. Kim DW, Kim WH, Kim CG. Dual-time-point FDG PET/CT: Is It Useful for Lymph Node Staging in Patients with Non-Small-Cell Lung Cancer? Nucl Med Mol Imaging. 2012;46(3):196-200. doi:10.1007/s13139-012-0141-0
18. Kim WH, Kim CG, Kim DW. Optimal CT Number Range for Adipose Tissue When Determining Lean Body Mass in Whole-Body F-18 FDG PET/CT Studies. Nucl Med Mol Imaging. 2012;46(4):294-9. doi:10.1007/s13139-012-0175-3*
19. Park SA, Yang CY, Choi SS, Kim WH. Assessment of cerebral hemodynamics to acetazolamide using brain perfusion SPECT in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Clin Nucl Med. 2011;36(2):158-9. doi:10.1097/RLU.0b013e3182073c0f*제1저자(공동 제1저자 포함)